Statistics for WaVe Life Sciences Ltd (id:6571 WVE)
Valuation metrics
Market cap
2.07B
Enterprise value
1.74B
Trailing P/E (ttm)
-25.02
Forward P/E
-13.84
PEG ratio
-13.84
Price/Sales (ttm)
38.58
Price/Book (mrq)
14.21
Enterprise Value/Revenue
32.38
Enterprise Value/EBITDA
-11.73
Overview
Shares outstanding
152.52M
Float
79.54M
Shares short
6.93M
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
917.31K
Average volume (90 days)
Price summary
52-Week low
3.50
52-Week high
16.74
52-Week change
62.92%
Beta
-1.21
50-Day moving average
14.09
200-Day moving average
8.03
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-265.84%
Operating margin
832.66%
Operational effectiveness
Return on assets
-34.04%
Return on equity
-243.82%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
-1.16
Gross profit (ttm)
0.00
EBITDA
-147,982,000.00
Net income to common (ttm)
-142,516,992.00
Diluted EPS (ttm)
-1.12
Quarterly earnings growth (yoy)
-115.60%
Balance sheet
Total cash (mrq)
310.95M
Total cash per share (mrq)
2.04
Total debt (mrq)
27.17M
Total Debt/Equity (mrq)
18.17
Current ratio (mrq)
190.10%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-140,616,992.00
Levered free cash flow (LFCF)
-392,500.00